The University of Manitoba campuses and research spaces are located on original lands of Anishinaabeg, Ininiwak, Anisininewuk, Dakota Oyate, Dene and Inuit, and on the National Homeland of the Red River Métis. More
University of Manitoba
Winnipeg, Manitoba Canada, R3T 2N2
The College of Pharmacy has a long tradition of excellence in pharmacy education, research, and service, with the professional program considered to be one of the top-ranked programs in Canada. With the need for ongoing development of new drug therapies, pharmacist are on the cutting edge of research and health-care delivery.
From day one, your PharmD curriculum focuses on patient care. You'll work directly with experienced preceptors, learning how to deliver the highest level of care and preparing for a rewarding career. This hands-on experience is a core part of your training, ensuring you feel confident and capable when you step into your own role as a pharmacist.
Whether you're interested in research that spans from the lab bench to patient care or making discoveries that impact communities, we offer a wide range of opportunities. Our areas of study include medicinal chemistry, pharmacology, pharmacogenetics, pharmacy practice, and more. Plus, our new concentration in Pharmacoepidemiology allows you to earn formal recognition of your expertise in this growing field within your MSc or PhD program.
To pursue graduate studies in pharmacy, you'll need an advisor who is ready to support you.
Exploring your options
If you're interested in working with a faculty researcher who isn’t listed, feel free to reach out to them directly to explore potential opportunities.
Reaching out
When you're ready to contact a faculty member about a graduate position, make sure to include:
| Faculty advisor | Research area |
|---|---|
| Abdullah Al Maruf | clinical pharmacology, precision medicine, knowledge translation, pharmacy education and practice |
| Hope Anderson | atrial fibrillation, cardiac hypertrophy, cardiac myocytes, molecular biotherapeutics, pressure myography, resistance arteries, translational pharmacotherapy |
| Anna M. Chudyk | social behavioural and administrative pharmacy; patient engagement in research and health care; pharmacy practice research; interdisciplinary collaborations; cardiac populations; innovative approaches to knowledge mobilization |
| Sherif Eltonsy | pharmacoepidemiology, evidence synthesis |
| Kaarina Kowalec | pharmacoepidemiology, pharmacogenomics, genomics |
| Ted Lakowski | novel cancer treatment and diagnostiPayam Peymanimethods, chromatin modification and epigenetics, LC-MS/MS and method development |
| Lucy Marzban | understanding molecular mechanisms underlying pancreatic β-cell failure in diabetes and developing new pharmacological strategies for treatment of diabetes |
| Shweta Mital | pharmacoeconomics, cost-effectiveness analyses, health policy evaluation |
| Samantha Pauls | immunometabolism, fatty acids, metabolic disease, inflammation |
| Payam Peymani | pharmacoepidemiology, comparative safety and effectiveness of medications, real-world evidence generation |
| Dake Qi | pro-inflammatory factors, metabolic dysfunction and heart disease |
| Jillian Stobart | aging, astrocytes, Alzheimer’s disease, molecular biotherapeutics, pericytes |
| Geoff Tranmer | medicinal chemistry |
| Dana Turcotte | opioid stewardship and safer prescribing; primary care collaborative team research; cannabis for chronic pain |
| Faculty advisor | Research area |
|---|---|
| Abdullah Al Maruf | clinical pharmacology, precision medicine, knowledge translation, pharmacy education and practice |
| Hope Anderson | atrial fibrillation, cardiac hypertrophy, cardiac myocytes, molecular biotherapeutics, pressure myography, resistance arteries), translational pharmacotherapy |
| Anna M. Chudyk | social behavioural and administrative pharmacy; patient engagement in research and health care; pharmacy practice research; interdisciplinary collaborations; cardiac populations; innovative approaches to knowledge mobilization |
| Kaarina Kowalec | effectiveness and safety, epidemiology, evaluation of medication use, genetics, genomics, neurology, psychiatry, schizophrenia |
| Ted Lakowski | Novel cancer treatment and diagnostic methods, chromatin modification and epigenetics, LC-MS/MS and method development |
Pharmacoepidemiology is a rapidly growing field, both in Canada and globally. With the rising demand to assess the effectiveness, safety, and value of new medications, many health agencies and pharmaceutical companies are eager to hire experts in this area.
The College of Pharmacy offers an exciting MSc and PhD concentration in pharmacoepidemiology. In this program, you'll complete core and elective courses, as well as a thesis focused on pharmacoepidemiology. You'll gain valuable skills in researching the effects of therapeutic agents on populations—preparing you for a rewarding career in this in-demand field.
A degree in pharmacy offers more flexibility than ever before, allowing you to choose a career path that best suits your interests, talents and lifestyle. For many, the most familiar role is in the pharmacy, providing patients with prescriptions, over-the-counter products and supplies, as well as offering education on medication use and safety. However, many pharmacists hold positions outside the pharmacy in hospital or primary care practice, regulatory authorities, government consultancy, academia and the pharmaceutical industry.
Through your master’s or PhD program, you’ll pursue in-depth research in areas from drug design and development to cell biology and therapeutic applications. Depending on your interests, you may decide to continue that work with a career in academia. However, with the analytical skills, critical thinking abilities and capacity for research you’ll develop in your graduate program, you will be a valuable asset to pharmaceutical companies, health care facilities and government agencies.
College of Pharmacy
Apotex Centre
750 McDermot Avenue West
University of Manitoba (Bannatyne campus)
Winnipeg, MB R3E 0T5 Canada
